Finland· FI-REL-REL64811
Rxulti
A brexpiprazole product containing brexpiprazole, registered in Finland by Paranova Oy. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Brexpiprazole is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AX16 (brexpiprazole), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Brexpiprazole · ATC N05AX16
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of brexpiprazole costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Brexpiprazole · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$8.31
The record
At a glance
Fimea (Finland)- Active substance
- Brexpiprazole
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- N05AX16
- ATC class
- Brexpiprazole
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa53953428EUR 77.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
209 interactions on record for brexpiprazole.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brexpiprazole · interactions on record
209 records
- 52 severe
- 157 moderate
Most severe, free to view
- ClotrimazoleA01AB18severe
- CimetidineA02BA01severe
- MetoclopramideA03FA01severe
- DiphenhydraminA04AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brexpiprazole in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRXULTIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- SpainRXULTI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULAOtsuka Pharmaceutical Netherlands B.V.
- IrelandRXULTI 4 mg Film-coated tabletOtsuka Pharmaceutical Netherlands B.V.
- IcelandRxultiOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsRXULTI 4 mg filmomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayRxultiOtsuka Pharmaceutical Netherlands B.V.
- PolandRXULTIOtsuka Pharmaceutical Netherlands B.V.
- BelgiumRxulti 4 mgOtsuka Pharmaceutical Netherlands
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rxulti
- Liechtenstein · Rxulti
- Norway · Rxulti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb402e93-e4ed-40be-a7b3-100ca5382887 GET /v1/drugs/cb402e93-e4ed-40be-a7b3-100ca5382887?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "4 mg",
"atc_label": "brekspipratsoli",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/18/1294/007",
"fimea_rel_id": "REL64811",
"authorised_at": "2025-11-21"
}See everything about brexpiprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.